BECN1 has been generally identified as a tumor-suppressing gene in the last decades because decreased BECN1 expression level is widely observed in various types of cancer, including breast cancer, glioblastoma multiforme, and ovarian and prostate cancer [68,69,70]. The gene discussed is BECN1; the disease is cancer.